The usefulness of in vivo gene expression investigations from peripheral white blood cells: A preliminary study

European Journal of Cancer Prevention

Volumn 8, Issue 4, 1999, Pages 331-334

  Ember, I ^a   Kiss, I ^b   Raposa, T ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Szent Istvan Hospital   (Hungary)

Author keywords

Cytostatic treatment; Gene expression; Leukaemia; Lymphoma; Oncogene; Tumour suppressor gene

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ARTICLE; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DRUG MONITORING; GENE EXPRESSION; GENE ISOLATION; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032841718     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199908000-00010     Document Type: Article

References (14)

1. Beer DG, Pilot HG (1989). Proto-oncogene activation during chemically induced hepatocarcinogenesis in rodents. Mutation Res 220: 1-10.
2. Boivin JF, Hutchinson GB (1981). Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease. J Natl Cancer Inst 67: 751-60.
3. Bosari S, Viale G (1995). The clinical significance of p53 aberrations in human tumors. Virchows-Arch 427: 229-41.
4. Chomczynsky P, Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-9.
5. Deegh HJ, Sanders J, Martin P et al. (1984). Secondary malignancies after marrow transplantation. Exp Hematol 12: 660-6.
6. Ember I, Raposa T, Varga Cs, Herceg L, Kiss I (1995a). Carcinogenic effects of cytostatic protocols in CBA/Ca mice. In Vivo 9: 65-70.
7. Ember I, Raposa T, Varga Cs, Kiss I (1995b). Effect of different cytostatic protocols on oncogene expression in CBA/Ca mice. Anticancer Res 15: 1285-8.
8. Ember I, Kiss I (1998). In vivo effects of CHOP protocol on onco and suppressor gene expression in a 'follow-up study'. In Vivo 12: 489-94.
9. Ember I, Kiss I, Nowrastch G, Raposa T (1998a). Effect of ABVD therapeutic protocol on oncogene and tumor suppressor gene expression in CBA/Ca mice. Anticancer Res 18: 1149-52.
10. Ember I, Kiss I, Vermes É (1998b). Early effect of cyclophosphamide on oncogene expression in vivo. In Vivo 12: 201-8.
11. Kasai Y, Takeda S, Takagi H (1996). Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis. Semin-Surg-Oncol 12: 155-9.
12. Rosner F, Grünwald HW, Zarrabi HM. (1982). Cancer after the use of alkylating and non-alkylating cytotoxic agents in man. Cancer Surv 1: 599-612.
13. Sakai M, Okuda A, Hatayama I, Sato K, Nishi S, Muramatsu M (1989). Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis. Cancer Res 49: 5633-7.
14. Varga Cs, Ember I, Raposa T (1991). Comparative studies on genotoxic and carcinogenic effects of different cytoststic protocols. I. In vivo cytogenetic analyses in CBA mice. Cancer Letters 60: 199-203.